Skip to main content


Figure 3 | Molecular Cancer

Figure 3

From: Combining phenotypic and proteomic approaches to identify membrane targets in a ‘triple negative’ breast cancer cell type

Figure 3

Venn diagram summary of MDA-MB-231 plasma membrane target antigens identified by each of the three detailed target identification methods. CD44 was identified using all three methods. Integrin α2 and integrin α3 were identified by both the hybridoma and proteomic methods. EGFR and CD73 were identified by both the phage display and proteomic methods.

Back to article page